Gunther Birznieks, SVP, Business Development at Vanda Pharmaceuticals Inc. (VNDA), sold 17,411 shares at $4.30 ($73K) on 2024-03-04, disclosed to the SEC on 2024-03-06.
Seasonal sale ($73k) by SVP, Business Development — this insider has traded VNDA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.30 | 8,727 | $38K | 51.1% |
| 2 | $4.13 | 8,684 | $36K | 48.9% |
| Total | $4.22 avg | 17,411 | $73K | 100% |
| Filing → |
| VNDA | SELL | 2022-03-02 | $305K | — | Filing → |
| VNDA | SELL | 2021-03-03 | $748K | — | Filing → |
| VNDA | SELL | 2020-03-04 | $363K | — | Filing → |